IDL Diagnostics AB (FRA:80R) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:80R IDL Diagnostics AB FRA:80R
55 GF Score
Price €0.03
GF Value €0.03
! 2 Warning Signs
View Full Analysis

What is IDL Diagnostics AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:80R
55GF Score
IDL Diagnostics AB FRA:80R
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IDL Diagnostics AB (FRA:80R) Overvalued in 2026?

Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued. The current stock price of €0.03 is trading 14.7% below its estimated GF Value™ of €0.03.

Key valuation signals for FRA:80R:

  • FFO:
  • GF Value™: €0.03 vs. price of €0.03 (14.7% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the FRA:80R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDL Diagnostics AB Business Description

Other Exchanges IDLDX:Sweden
Address Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score

Get the complete analysis for FRA:80R

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.03
GF Value